Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron
- 6 November 2018
- journal article
- research article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 31 (3) , e13499
Abstract
Background: Cisplatin is a highly emetogenic antineoplastic drug and induces peripheral neuropathy when given in cycles. Granisetron, a 5‐HT 3 antagonist, is clinically used to prevent chemotherapy‐induced nausea/emesis and abdominal pain in irritable bowel syndrome. The effects of cisplatin on visceral sensitivity and those of granisetron in the context of cancer chemotherapy are not well known. Methods: Adult male Wistar rats received two intraperitoneal injections 30 minutes apart: granisetron (1 mg kg −1 )/vehicle and cisplatin (6 mg kg −1 )/vehicle. Thereafter, nausea‐like behavior was measured as bedding intake for 4 hours, and gastric dysmotility was measured radiographically for 8 hours. Gastric weight and size were determined ex vivo and samples of the forestomach, corpus, ileum, and colon were obtained for histological analysis at 4 and 30 hours after cisplatin/vehicle. Visceral sensitivity was measured as abdominal contractions in response to mechanical intracolonic stimulation 2 hours after cisplatin/vehicle. Key Results: Cisplatin‐induced bedding intake and gastric dysmotility, and granisetron blocked these effects, which occurred in the absence of frank mucositis. Visceral sensitivity was reduced to a similar extent by both drugs alone or in combination. Conclusions and Inferences: Cisplatin‐induced bedding intake and gastric dysmotility were blocked by granisetron, confirming the involvement of serotonin acting on 5‐HT 3 receptors. Unexpectedly, visceral sensitivity to colonic distension was reduced, to the same extent, by cisplatin, granisetron, and their combination, suggesting important mechanistic differences with nausea and gastric dysmotility that warrant further investigation.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (SAF2012‐40075‐C02‐01)
- Comunidad de Madrid
- European Social Fund Plus (PEJ15/BIO/TL#x2010;0580).)
This publication has 58 references indexed in Scilit:
- Effects of oxaliplatin on mouse myenteric neurons and colonic motilityFrontiers in Neuroscience, 2013
- Acute Oxycodone Induces the Pro-Emetic Pica Response in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with picaNeurogastroenterology & Motility, 2010
- Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with picaAutonomic Neuroscience, 2008
- Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the ratLife Sciences, 2007
- Basic and clinical aspects of visceral sensation: transmission in the CNSNeurogastroenterology & Motility, 2005
- Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoeaThe Lancet Oncology, 2005
- Pica in rats is analogous to emesis: An animal model in emesis researchPharmacology Biochemistry and Behavior, 1993
- A peculiar toxicity manifested by platinum(II)amines in rats: Gastric distension after intraperitoneal administrationChemico-Biological Interactions, 1981